Papuloerythematous Drug Eruption
Papuloerythematous drug eruption is a skin condition characterized by red, raised bumps that appear as a reaction to certain medications, often causing discomfort and irritation.
TAR-0520 Gel for Folliculitis in Colorectal Cancer Patients
We are testing a new gel to see if it is safe and effective for preventing skin irritation in patients using EGFR inhibitors for colorectal cancer. This study focuses on its use on the face and chest.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
EGFR Inhibitor-Induced Folliculitis
EGFR inhibitor-induced folliculitis is a skin condition that occurs as a side effect of EGFR inhibitors, leading to inflammation of hair follicles, resulting in red, itchy bumps and sometimes pustules.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have metastatic colorectal cancer?
- Have you received treatment with EGFR inhibitors like cetuximab or panitumumab in the past two years?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Tar-0520
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Sainte Catherine Institut Du Cancer Avignon-Provence
Medical oncology
Avignon, France
Centre Hospitalier Universitaire De Bordeaux
Digestive oncology
Canéjan, France
Centre Hospitalier Universitaire Reims
Gastroentérologie - Cancérologie digestive
Cormontreuil, France
Sponsor: Tarian Pharma
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.